weaning. Dams were followed through the subsequent mating and pregnancy. Maternal pST injections from d 25 to 100, but not d 25 to 50, increased mean piglet birth weight by 11.6% in sows (P ≤ 0.001) and by 5.6% in gilts (P = 0.008). Both pST treatments decreased litter size by approximately 0.6 live-born piglets (each P ≤ 0.025). In sows, maternal pST treatment from d 25 to 100 increased culls at weaning (P = 0.037). In remated dams, prior treatments did not affect (P > 0.1) the weaning-remating interval, conception rate, or subsequent litter size. Greater pST-induced birth weight increases in sows than in gilts may mean that underlying metabolic or placental mechanisms for pST action are constrained by maternal competition for nutrients in rapidly growing gilts.
INTRODUCTION
Fetal growth and birth weight predict neonatal survival and postnatal growth rates and efficiency in pigs, as in other species. Increased size at birth improves neonatal survival (Fahmy and Bernard, 1971 ; van der Lende and de Jager, 1991; Roehe and Kalm, 2000) , stimulates sow milk production and the growth of suckling piglets (Campbell and Dunkin, 1982; King et al., 1997) , and increases muscle fiber numbers and postweaning growth (Wigmore and Stickland, 1983; Dwyer et al., 1993; Gondret et al., 2005; Rehfeldt and Kuhn, 2006) . In the pig, however, fetal growth and birth weight are constrained by competing maternal demands in growing adolescent animals, by large and variable litter size, and by the restricted maternal nutrition used in commercial pig production systems during pregnancy.
Daily maternal injections of gilts with porcine ST (pST) during early-mid pregnancy (d 30 to 43, d 28 to 40, or d 25 to 50) increase fetal growth and progeny muscle size, but do not increase progeny birth weight (Kelley et al., 1995; Sterle et al., 1995 Sterle et al., , 1998 Gatford et al., 2000 Gatford et al., , 2003 Gatford et al., , 2004 . More sustained pST treatment, from d 25 to 100, increases progeny birth weight in gilts under commercial conditions (Gatford et al., 2004) . We recently reported that maternal pST injections from d 25 to 50 of pregnancy increased fetal growth at d 50 to Maternal responses to daily maternal porcine somatotropin injections during early-mid pregnancy or early-late pregnancy in sows and gilts a similar extent in mature sows and in gilts (Gatford et al., 2009) . Whether sows are able to maintain increased fetal size to birth if maternal pST treatment stops in mid-pregnancy, the extent to which longer term maternal pST treatment increases progeny size at birth, and the consequences for maternal and piglet outcomes are not known. We therefore tested the hypotheses that daily pST injections during early-mid pregnancy (d 25 to 50) or early-late pregnancy (d 25 to 100) in gilts and sows would increase progeny birth weight, lactation growth rate, and neonatal survival without adversely affecting subsequent reproductive performance.
MATERIALS AND METHODS
The study was designed in accordance with the Australian Code of Practice for the Care and Use of Animals for Scientific Purposes (National Health and Medical Research Council of Australia, 2004) and was approved by the University of Adelaide and the Rivalea Australia (formerly QAF Meat Industries) Animal Ethics Committees.
Animals
The in vivo studies were conducted under commercial conditions at Rivalea Australia (Corowa, Australia). Large White × Landrace (PrimeGro Genetics, Corowa, Australia) parity 0 sows (gilts) were mated at 23 wk of age, and mature Large White × Landrace (PrimeGro Genetics) sows (second or third parity at mating) were mated at the first postweaning estrus. The study was conducted over 12 wk, with 30 gilts and 30 sows allocated in equal numbers to each treatment in each replicate week of the study (2 × 3 factorial arrangement of treatments, n = 120 dams/treatment and parity in total, 720 dams allocated to the entire study). Gilts were mated 3 times by AI using semen (3 × 10 9 sperm) from commercial hybrid boars on the morning of detected estrus in the presence of a boar, followed by an afternoon mating and a third mating the next morning. Sows were mated on the morning of detected estrus and 24 h later by AI, as described above. The day of first AI was taken as d 1 of pregnancy. Pregnancy was confirmed by ultrasound scanning at d 23 to 24 after mating. Gilts were individually housed in stalls from mating for 6 wk, and then housed in groups of 8 to 12, at 1.8 m 2 /gilt, until entry into the farrowing house after 15 wk of pregnancy at d 108 to 110, when they were transferred to individual farrowing crates for farrowing and lactation. Sows were housed individually throughout pregnancy and were transferred to the same farrowing house as the pregnant gilts after 15 wk of pregnancy. After weaning, all sows were returned to individual stalls for approximately 1 wk for mating, and were then transferred to ecoshelters (Croft Polythene Greenhouses, Yarra Glen, Australia), where animals were housed in groups of approximately 80 mixed-parity sows (2.5 m 2 /sow) for the subsequent pregnancy, before entering the farrowing house again at approximately d 109 of pregnancy.
Nutrition and Treatments
From mating until entry into the farrowing shed, gilts were fed 2.2 kg/d and sows were fed 2.5 kg/d of a dry sow diet (13.5 MJ of DE/kg, 16.0% total protein, 0.80% total lysine) once daily in the morning. After confirmation of pregnancy, gilts and sows were ranked by BW within parity for each replicate week of the study and were allocated alternately to each treatment group (n = 120 per treatment and parity in total). Control gilts and sows were not injected, to enable comparison with performance under current commercial management. Gilts and sows allocated to the pST-injection groups were injected intramuscularly daily with 1 mL of sterile water containing 2.5 or 4.0 mg of pST, respectively, which was calculated to provide a dose of approximately 15 µg of pST/kg per day in both parity groups, based on previous BW data from the herd. Gilts and sows were injected daily with pST from d 25 of pregnancy until d 50 (short-term pST) or d 100 of pregnancy (long-term pST). Dams entered the farrowing house between d 108 and 110 of pregnancy (d 109 ± 1) and were fed 3 kg/d of a lactation diet (14.9 MJ of DE/kg, 19.2% total protein, 0.89% total lysine) until farrowing, and were then fed this lactation diet 3 times per day to appetite until weaning. Gilts and sows farrowed naturally at term (referred to as the treatment pregnancy). Within 24 h of farrowing, a minimal crossfostering approach was used to equalize the litter size to 10 piglets in gilt litters and 12 piglets in sow litters where possible. Sows were weaned in the fourth week of lactation on a set day each week. Litters were weaned at 26.6 ± 0.1 d after birth, and all dams were mated by AI at the first postweaning estrus. Dam removals and reasons for removal were recorded throughout the treatment pregnancy, throughout lactation, and up to the subsequent farrowing (subsequent pregnancy). Dams were fed 2.6 kg/d of a commercial dry sow diet (12.9 MJ of DE/kg, 14.5% total protein, 0.62% total lysine) throughout the subsequent pregnancy and were transferred to the lactation diet on entry into the farrowing house, as described above.
Maternal and Progeny Measures
Pregnant dams were weighed and backfat depth was measured by ultrasound at the P2 site (65 mm from the midline over the final rib, using a linear-array 3.5-mHz live ultrasound instrument; Noveko, Montréal, Canada) before the beginning of treatments at d 20 to 24 of pregnancy, at d 50 of pregnancy, on transfer to the farrowing shed at d 104 to 111 of pregnancy, and at weaning. A subset (approximately 60% of dams to minimize disturbance of the dams on the day of birth) were weighed and P2 backfat was recorded on the day of farrowing for each replicate week of the study. Numbers of live piglets, stillbirths, and mummified piglets were recorded within 24 h of birth. Total litter weight and number were recorded on the day of delivery, after fostering, at d 14 of lactation, and at weaning. Preweaning piglet losses, reasons for removal, and dates at removal were recorded throughout lactation. Numbers of live piglets, stillbirths, and mummified piglets were recorded within 24 h of birth for the subsequent pregnancy.
Statistical Analyses
The effects of maternal parity, treatment, and their interaction on maternal and litter outcomes were analyzed by 2-way ANOVA. Replicate week was also included as a factor in full factorial statistical models in analyses of maternal BW, P2, and lactation performance, which varied between replicate weeks. Replicate week did not affect (P > 0.05) litter size or piglet size at birth and was not included in these models. Specific contrasts were performed to test a priori the hypotheses that short-term maternal pST treatment or long-term maternal pST treatment would increase litter weight and mean piglet birth weight, but would not impair subsequent maternal reproductive performance. Chisquare analysis was used to test the effects of maternal parity and treatment, and treatment within each parity, on dam removals. Pearson correlation tests were used to investigate relationships between mean litter birth size, survival, and preweaning growth. All statistical analyses were carried out using SPSS (SPSS Inc., Chicago, IL), and data are presented as mean ± SEM unless otherwise indicated.
RESULTS

Maternal BW and Backfat Depth
Maternal BW at d 25 of pregnancy, before commencing the injections, was greater in sows than in gilts (P < 0.001; gilts: 164.9 ± 0.8 kg; sows: 238.9 ± 1.1 kg), tended to vary with replicate week (P = 0.083), and did not differ between treatments (P = 0.998). Maternal pST treatment increased maternal BW at the end of treatment, at d 50 in all pST-treated dams (P ≤ 0.004; Figure 1 ), and at d 109 in dams treated with pST from d 25 to 100 (P ≤ 0.001), regardless of parity. In those dams treated with pST from d 25 to d 50 of pregnancy, maternal BW returned to values similar to the controls after the end of treatment, and these animals had BW similar to controls at d 109 of pregnancy (P > 0.45; Figure 1 ). The daily maternal BW change from d 50 of pregnancy to d 109 was greater in pigs treated with pST until d 100 of pregnancy than in controls (P = 0.035), but was less in pigs treated with pST until d 50 of pregnancy than in controls (P = 0.020). Gilts grew faster during this period than sows (P ≤ 0.001), and the difference in rate of BW gain between parities varied between replicate weeks of the study (P = 0.035).
Maternal BW on the day after farrowing was increased in dams treated with pST from d 25 to 100 of pregnancy (P = 0.01), but not in dams treated with pST from d 25 to 50 of pregnancy (P > 0.7) compared with controls. Dams that were gilts during treatment were lighter on the day after farrowing than were sows (P ≤ 0.001), and the BW difference between parities varied with replicate week of the study (P = 0.016). Maternal BW at weaning did not differ between treatment groups (P > 0.4, Figure 1 ). Body weight at weaning was less in dams that were gilts during treatment (P ≤ 0.001) and varied between replicate weeks of the study (P = 0.040), but the effects of parity and treatment did not differ with replicate week (P > 0.17 for each). Daily maternal BW loss during lactation tended to be greater in dams treated with pST from d 25 to 50 of pregnancy (P = 0.068; 477 ± 44 g/d) and was increased in dams treated with pST from d 25 to 100 of pregnancy (P = 0.011; 643 ± 54 g/d) compared with controls (465 ± 59 g/d). Sows also lost BW more rapidly than gilts during lactation (P ≤ 0.001; sows: 722 ± 46 g/d; gilts: 333 ± 34 g/d). Maternal BW loss during lactation varied between replicate weeks (P ≤ 0.001), but effects of parity and treatment did not differ with replicate week (P > 0.16 for each).
Maternal P2 backfat depth (Figure 2 ; overall mean: 15.3 ± 0.1 mm) at d 25 of pregnancy, before commencement of injections, did not differ between parities (P > 0.8) or treatment groups (P > 0.9), but varied between replicate weeks (P ≤ 0.001), and effects of parity also varied between replicate weeks (P = 0.001). Maternal P2 backfat depth at d 50 of pregnancy was also unaffected by parity or treatment (P > 0.4 for each) and varied with replicate week (P ≤ 0.001), and effects of parity varied with replicate week (P ≤ 0.001). Dams treated with pST from d 25 to 100 of pregnancy gained P2 backfat depth more slowly between d 50 and 109 of pregnancy than did control dams (P = 0.015), whereas the rate of P2 backfat gain from d 25 to 109 was not different from controls in dams whose pST treatment stopped at d 50 (P > 0.6). Consequently, maternal P2 backfat depth before farrowing was greater in gilts than sows (P = 0.001) and was reduced in dams treated with pST from d 25 to 100 of pregnancy (P = 0.001), but was not reduced in those treated from d 25 to 50 only (P = 0.165) and varied with replicate week (P ≤ 0.001). Rate of maternal P2 backfat loss during lactation did not differ between treatments (P > 0.6) or parities (P > 0.2), but did vary between replicate weeks (P ≤ 0.001). Consequently, maternal P2 backfat depth at weaning (Figure 2 ) was less in dams treated with pST from d 25 to 100 than in controls (P = 0.034), but was not reduced in dams whose treatment was finished at d 50 (P > 0.6).
Litter Outcomes for Treatment Pregnancy
Effects of maternal treatment on gestation length differed between parities (P = 0.033; Table 1 ). In gilts, Porcine somatotropin in pregnant gilts and sows . Fostering was performed on the day of birth to achieve litter sizes at the beginning of lactation of 10 piglets (where possible) in first-lactation sows and 12 piglets in older lactating sows. Dams were weighed and P2 backfat depth was measured by ultrasound on d 25 of pregnancy (before the first injections) and on d 50 and 109 of pregnancy. Body weight and P2 backfat depth were measured in approximately 60% of dams on the day of farrowing and in all dams at weaning. Maternal BW was greater in sows than in gilts at each day of pregnancy or lactation (each P ≤ 0.001). Overall, maternal BW was increased in all pST-treated dams compared to controls at d 50 (P ≤ 0.004). At d 109, maternal BW was increased in dams treated with pST from d 25 to 100 (P ≤ 0.001), but not in dams treated with pST from d 25 to 50 of pregnancy (P > 0.45). Maternal BW on the day after farrowing was greater in dams treated with pST from d 25 to 100 of pregnancy (P = 0.01), but not in dams treated with pST from d 25 to 50 of pregnancy (P > 0.7), compared with controls. Maternal BW at weaning did not differ between treatment groups (P > 0.4). . Fostering was performed on the day of birth to achieve litter sizes at the beginning of lactation of 10 piglets (where possible) in first-lactation sows and 12 piglets in older lactating sows. Dams were weighed and P2 backfat depth was measured by ultrasound on d 25 of pregnancy (before first injections) and on d 50 and 109 of pregnancy. Body weight and P2 backfat depth were measured in approximately 60% of dams on the day of farrowing and in all dams at weaning. Maternal P2 depth at d25 and 50 of pregnancy did not differ between parities or treatment groups (each P > 0.4). Maternal P2 backfat depth before farrowing was greater in gilts than sows (P = 0.001). Maternal P2 backfat depths before farrowing and at weaning were reduced in dams treated with pST from d 25 to 100 of pregnancy (P = 0.001 and P = 0.034, respectively), but were not reduced in those treated from d 25 to 50 only (P = 0.165 and P > 0.6, respectively). gestation length was unaffected by maternal treatment, but in sows, gestation length was reduced after pST treatment from d 25 to 100 of pregnancy (P ≤ 0.001; Table 1 ).
Numbers of total (P ≤ 0.001), live-born (P ≤ 0.001), and stillborn piglets (P = 0.010) were greater in sows than in gilts (Table 1) . Numbers of mummified piglets tended to be greater in sow litters than in gilt litters (P = 0.062), were greater in litters from dams treated with pST from d 25 to 50 of pregnancy (P = 0.014) than in controls, and were not altered in litters from dams that were treated with pST from d 25 to 100 of pregnancy (P = 0.146). Total piglet numbers were less in litters from dams treated with pST from d 25 to 100 than in controls (P = 0.038), and were not reduced in litters from dams treated with pST from d 25 to 50 of pregnancy (P = 0.166). Numbers of stillborn piglets tended to be increased in litters from dams treated with pST from d 25 to 50 compared with controls (P = 0.079) and were not altered in litters from dams treated with pST from d 25 to 100 of pregnancy (P > 0.9). Consequently, the numbers of live-born piglets in each litter were reduced by approximately 0.6 piglets/litter after pST treatment, either from d 25 to 50 of pregnancy (P = 0.018) or from d 25 to 100 of pregnancy (P = 0.024), compared with control litters (Table 1) .
Mean piglet birth weight (Table 1) was greater in sows than in gilts (P ≤ 0.001) and was increased by maternal pST treatment to a greater extent in sows than in gilts (treatment × parity, P = 0.051). In gilts, maternal treatment affected mean birth weight (P = 0.029) such that mean piglet birth weight was increased in litters from dams treated with pST from d 25 to 100 of pregnancy (P = 0.008), but not in litters from dams treated with pST from d 25 to 50 of pregnancy (P = 0.114). Similarly in sows, maternal treatment affected mean piglet birth weight (P ≤ 0.001), with increased birth weight in progeny of dams treated with pST from d 25 to 100 of pregnancy (P ≤ 0.001), but not in litters from sows treated with pST from d 25 to 50 (P = 0.147). When corrected for litter size, mean piglet birth weight was greater in sows than in gilts (P ≤ 0.001), and effects of maternal treatment differed between parities (treatment × parity, P = 0.01; Table 1 ). Effects of treatment on progeny birth weight were therefore analyzed separately for sows and gilts, using the mean litter sizes for each parity. In gilts, birth weight corrected for a mean gilt litter size of 12.02 piglets was altered by maternal treatment (P = 0.039) such that mean piglet birth weight was increased in litters from gilts treated with pST from d 25 to 100 of pregnancy (P = 0.014, 1.49 ± 0.02 kg) and tended to be increased in litters from gilts treated with pST from d 25 to 50 of pregnancy (P = 0.071, 1.47 ± 0.02 kg) relative to control litters (1.42 ± 0.02 kg). In sows, birth weight corrected for a mean sow litter size of 13.03 piglets was also altered by maternal treatment (P ≤ 0.001) such that mean piglet birth weight was increased in litters from sows treated with pST from d 25 to 100 of pregnancy (P ≤ 0.001, 1.72 ± 0.02 kg), but was not increased in litters from sows treated with pST from d 25 to 50 of pregnancy (P > 0.5, 1.59 ± 0.02 kg) relative to control litters (1.57 ± 0.02 kg).
Lactation Feed Intake, and Litter Survival and Growth
The duration of lactation was shorter in sows than in gilts (P ≤ 0.001; sows: 25.9 ± 0.1 d; gilts: 27.4 ± 0.1 d) because of differences in mating dates between parities and a common weaning date for each replicate week. On entry into the farrowing house, gilts were approximately 1.8 d further advanced in gestation than sows. Lactation lengths were similar between treatments in gilts (P > 0.27). Because of the shorter gestation length in sows treated with pST from d 25 to 100, this group had longer lactations than control sows (P ≤ 0.001), whereas lactation lengths of sows treated with pST from d 25 to 50 were not different from controls (P > 0.7). Litter size after fostering was greater in sows than in gilts (P ≤ 0.001) and did not differ between treatments (Table 2) . Mean litter size after fostering in gilts was greater than the target of 10 piglets because insufficient numbers of dams were available to reduce the litter size to 10 in all gilt litters. Litter sizes remained greater for sows than for gilts throughout lactation, and the numbers of piglets that were removed or that died between fostering on d 1 and weaning did not differ between maternal treatments (P > 0.5; Table 2 ), whereas effects of parity varied between replicate week (P = 0.041), and there was no effect of parity overall (P = 0.109). Piglet losses (deaths and removals) during lactation were negatively correlated with mean piglet BW after fostering, overall (R = −0.277, P ≤ 0.001, n = 506) and within each parity (P ≤ 0.001 for each).
Sows ate more feed each day than gilts throughout lactation (P ≤ 0.001), feed intake varied between replicate weeks (P ≤ 0.001), and effects of maternal treatments on feed intake differed between parities (treatment × parity, P = 0.012; Table 2 ). Daily feed intake during lactation tended to differ between treatments in sows (P = 0.064) and differed between replicate weeks (P ≤ 0.001), tending to be less in sows that were treated with pST from d 25 to 50 of pregnancy than in controls (P = 0.090), but not differing between sows treated with pST from d 25 to 100 and controls (P > 0.5). In gilts, daily feed intake during lactation varied with treatment (P ≤ 0.001) such that lactation feed intake was increased in gilts treated with pST from d 25 to 100 of pregnancy (P = 0.001) or from d 25 to 50 of pregnancy (P = 0.021) relative to control gilts (Table  2 ) and varied with replicate week (P ≤ 0.001). Total litter weight gain from fostering to weaning (Table 2) was greater in sows than in gilts (P ≤ 0.001) and varied between replicate weeks (P ≤ 0.001), and the effects of maternal treatment differed between parities (P = 0.022). Total litter weight gain did not differ between maternal treatments in gilts (P > 0.3), but was affected Mean birth weight was altered by maternal treatment in gilts (P = 0.029) and in sows (P ≤ 0.001). Maternal pST treatment from d 25 to 100 of pregnancy increased mean birth weight relative to control litters in gilts (P = 0.008) and in sows (P ≤ 0.001), and maternal pST treatment from d 25 to 50 of pregnancy did not increase mean birth weight in either parity (P > 0.1 for each).
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Corrected to a mean total litter size of 12.53 piglets overall and within each parity (gilts: 12.02 piglets born; sows: 13.03 piglets born) for analyses of the treatment × parity interaction.
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Mean birth weight, corrected for litter size, was altered by maternal treatment in gilts (P = 0.039) and in sows (P ≤ 0.001). Maternal pST treatment from d 25 to 100 of pregnancy increased corrected mean birth weight relative to control litters in gilts (P = 0.014) and in sows (P ≤ 0.001), and maternal pST treatment from d 25 to 50 of pregnancy tended to increase corrected mean birth weight relative to control litters in gilts (P = 0.071), but not in sows (P = 0.501). Table 2 . Effects of maternal treatment and parity on lactation outcomes µg of pST/kg per day) from d 25 to 50 of pregnancy (short-term pST) or from d 25 to 100 of pregnancy (long-term pST). Fostering was performed on the day of birth to achieve litter sizes at the beginning of lactation of 10 piglets (where possible) in first-lactation sows and 12 piglets in older lactating sows. Lactating pigs were fed 3 times daily to appetite, and the feed offered was recorded daily. Litter size and piglet BW were recorded after the completion of fostering, on the day of birth, on d 14 of lactation, and before weaning.
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Daily feed intakes during lactation were affected by treatment in gilts (P ≤ 0.001), with a similar trend in sows (P = 0.064). In gilts, lactation feed intake was increased in dams treated with pST from d 25 to 100 of pregnancy (P ≤ 0.001) and in dams treated with pST from d 25 to 50 of pregnancy (P = 0.021) relative to control gilts. In sows, lactation feed intake was not different in dams treated with pST from d 25 to 100 of pregnancy (P > 0.5) and tended to be decreased in dams treated with pST from d 25 to 50 of pregnancy (P = 0.090) relative to control sows. Data are means ± SEM.
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Litter weight gain throughout lactation was not affected by maternal treatments in gilts (P = 0.338), but was affected by maternal treatment in sows (P = 0.014). Litter weight gain throughout lactation was not different in sows treated with pST from d 25 to 100 of pregnancy (P = 0.217), but tended to be decreased in sows treated with pST from d 25 to 100 of pregnancy (P = 0.085) relative to litters of control sows.
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Mean piglet growth rate from fostering to weaning was not affected by maternal treatments in gilts (P = 0.436), but tended to be affected by maternal treatments in sows (P = 0.060). Mean piglet growth rate from fostering to weaning was not different in sows treated with pST from d 25 to 100 of pregnancy (P = 0.309), but was decreased in sows treated with pST from d 25 to 100 of pregnancy (P = 0.018) relative to litters of control sows.
by treatment in sows (P = 0.014). Effects of treatment on litter weight gain over the lactation reflected mostly differences between the 2 groups of pST-treated sows because total litter weight gain over the lactation was less in sows treated with pST from d 25 to 50 of pregnancy compared with litters of sows treated with pST from d 25 to 100 of pregnancy (P = 0.015). Relative to control sows, total litter weight gain over the lactation tended to be less in sows that were treated with pST from d 25 to 50 (P = 0.085) and was not different in sows treated with pST from d 25 to 100 (P = 0.217; Table 2 ). Mean piglet BW after fostering ( Figure 3 ) were increased in litters from dams treated with pST from d 25 to 50 of pregnancy (P = 0.011) and in litters from dams treated with pST from d 25 to 100 of pregnancy (P ≤ 0.001), were greater in litters from sows than in those from gilts (P ≤ 0.001), and did not vary with replicate week of the study (P = 0.194). Mean piglet BW at d 14 of lactation ( Figure 3 ) were increased after maternal pST treatment from d 25 to 100 of pregnancy (P = 0.037), were not increased after maternal pST treatment from d 25 to 50 of pregnancy (P > 0.5), were greater in sow than in gilt progeny (P ≤ 0.001), and varied with replicate week of the study (P = 0.009). Mean piglet weaning weights ( Figure 3) were increased after maternal pST treatment from d 25 to 100 of pregnancy (P = 0.017), but were not increased after maternal pST treatment from d 25 to 50 of pregnancy (P > 0.8). Mean piglet weaning weights were also greater in sow progeny than in gilt progeny (P ≤ 0.001) and varied between replicate week (P ≤ 0.001). Piglet growth rates from fostering to d 14 of lactation and from d 14 of lactation to weaning (Table 2) were faster in sow litters than in gilt litters (P ≤ 0.001 for each period), were not affected by maternal treatments (P > 0.4 for each period), and varied between replicate weeks of the study (P ≤ 0.05 for each period). Piglet growth rates over the whole lactation, from fostering to weaning, were greater in sow than in gilt litters (P ≤ 0.001), varied between replicate weeks of the study (P ≤ 0.001), and differed in effects of maternal treatment between parities (P = 0.048). In gilt litters, piglet lactation growth rates were not affected by maternal treatment (P > 0.4). In sow litters, piglet lactation growth rates were reduced in litters from sows treated with pST from d 25 to 50 (P = 0.018), but were not changed in litters from sows treated with pST from d 25 to 100 of pregnancy (P > 0.3) compared with control litters (Table 2) .
Maternal Removals During Treatment Pregnancy and Subsequent Lactation
The numbers of dams removed between the commencement of the study and entry into the farrowing house (d 25 to 109), or from late pregnancy through . Fostering was performed on the day of birth to achieve litter sizes at the beginning of lactation of 10 piglets (where possible) in first-lactation sows and 12 piglets in older lactating sows. Lactating pigs were fed 3 times daily to appetite, and the feed offered was recorded daily. Litter size and piglet BW were recorded after the completion of fostering, on the day of birth, on d 14 of lactation, and before weaning. Maternal pST treatment from d 25 to 50 of pregnancy increased mean piglet BW after fostering (P = 0.011), but not at d 14 of lactation (P > 0.5) or at weaning (P > 0.8). Maternal pST treatment from d 25 to 100 of pregnancy increased mean piglet BW after fostering (P ≤ 0.001), on d 14 of lactation (P = 0.037), and at weaning (P = 0.017). Mean piglet BW was greater in litters from sows than those from gilts, after fostering, at d 14 of lactation, and at weaning (each P ≤ 0.001).
lactation to weaning (d 109 of pregnancy to weaning), were not different between parities or between maternal treatment groups overall (Table 3) . From the commencement of treatments until entry into the farrowing house, however, numbers of gilts removed differed between treatments (P = 0.024) such that 12% of gilts treated with pST from d 25 to d 100 of pregnancy were removed before entry into the farrowing house, compared with a 5% removal rate in controls (P = 0.062). Although these removals reflected a variety of causes (including 4 d 25 to 100 pST-treated gilts not transferred to the farrowing house for unknown reasons), it is important to note that there were no differences in rates of pregnancy loss between treatments, and similar numbers of gilts in each treatment were culled for physical reasons (2 control, 1 d 25 to 50 pST, 3 d 25 to 100 pST). Maternal parity and treatment did not affect (P > 0.1) total dam removals during farrowing and lactation (Table 3) . Rates of farrowing difficulties and lactation failure also did not differ (P > 0.1) between groups, despite differences in piglet size and lactational demand (Table 3 ).
Subsequent Maternal Reproductive Performance
A total of 500 dams remained on the trial at weaning from the lactation immediately after the treatment pregnancy (242 gilts and 258 sows). Removal of dams between weaning and the subsequent mating was greater in sows than in gilts (P ≤ 0.001), was not affected by maternal treatment in gilts (P = 0.99), and varied with maternal treatment in sows (P = 0.037; Table 4 ). In sows, removals before the subsequent mating were greatest in sows treated with pST from d 25 to 100 of the preceding pregnancy (Table 4 ). The majority of the 18 sows culled before mating in this group were removed either because of foot and leg problems (9 of 18) or because of poor body condition at weaning (6 of 18). Sows that were removed from the herd before remating (33 of 258 weaned) were thinner (P = 0.001) at d 25 of pregnancy before commencing treatment, were thinner (P = 0.003) and tended to be lighter (P = 0.068) on the day after farrowing, lost more BW (P = 0.003) and backfat depth (P = 0.023) during lactation, weaned heavier litters (P = 0.024) with a greater litter weight gain during lactation (P = 0.008), and ate less during lactation (P = 0.005) compared with the sows that remained in the herd and that were remated after the treatment pregnancy and lactation.
A total of 456 dams were mated at the first postweaning estrus. The weaning-remating interval did not differ between sows and gilts from the treatment pregnancy (P = 0.135) or between maternal treatment groups in the treatment pregnancy (P = 0.535). The proportion of dams that farrowed after this subsequent mating tended to be greater in gilts than in sows (P = 0.069; gilts: 80.7%; sows: 73.6%), largely because of parity differences in conception rates (Table 4) . Treatment in the previous pregnancy did not affect subsequent litter size (P > 0.16 for all measures). The numbers of total born (12.0 ± 0.2), live-born (11.0 ± 0.2), and mummified (0.20 ± 0.03) piglets were similar in dams that were gilts or sows during the previous (treatment) pregnancy (P > 0.1 for each). Parity did affect the numbers of stillborn piglets, which were greater in sows of greater parity (gilts at the previous pregnancy: 0.8 ± 0.1; sows at the previous pregnancy: 1.2 ± 0.1; P = 0.024).
DISCUSSION
Sustained maternal pST treatment, from d 25 to 100 of pregnancy, increased mean progeny birth weight in both parities, with the magnitude of the response approximately 2-fold greater in sow litters (+180 g, 11.6%) than in gilt litters (+80 g, 5.6%). Thus, maternal factors associated with adolescent and primiparous (gilt) pregnancies may limit the responses that underlie pST-induced increases in fetal growth. Our results are consistent with maternal ST acting as a driver of fetal growth, including previous reports of decreased maternal ST in human pregnancies with poor fetal growth (Mirlesse et al., 1993; Chowen et al., 1996) . Potential mechanisms for effects of pST on fetal growth include mobilization of maternal nutrient reserves for fetal growth, which could be limited in gilts that are themselves growing. In early, mid, or late gestation, maternal treatment with pST at doses at least 2-fold greater than those used in the present study increased or tended to increase maternal plasma glucose and insulin concentrations (Kveragas et al., 1986; Schneider et al., 2002; Gatford et al., 2003) . Increased maternal plasma glucose drives increased fetal growth, as seen in infants of mothers with diabetes during pregnancy (Cardell, 1953) . In castrated male pigs, daily ST injections reduced whole-body insulin sensitivity within a day of the initial injection (Kerber et al., 1998) . Whether elevated ST decreases insulin sensitivity similarly in pregnant sows and gilts, and hence increases glucose transport across the placenta and increases fetal growth, has not been evaluated. An increased plasma insulin:glucose ratio and increased plasma insulin and glucose concentrations occurred in gilts treated with pST doses 2 and 4 times greater than those in the present study (Gatford et al., 2003) , providing indirect evidence of insulin resistance in pST-treated gilts. We have also reported increased fetal plasma glucose at d 50 in fetuses from gilts treated from d 25 to 50 with pST doses similar to those in the present study, although pST did not affect maternal plasma insulin or glucose concentrations in that small study (Gatford et al., 2000) . Increased allantoic and amniotic glucose concentrations have been reported at d 28 in gilts treated with pST from d 10 to 27 of pregnancy, also consistent with increased glucose transport to the fetus (Rehfeldt et al., 2001) . Placental growth and function may also be increased directly or indirectly by maternal pST, given that the porcine placenta expresses receptors for pST as well as for IGF-I Chi-square analysis.
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In sows, dam removals during pregnancy did not differ between treatments (P = 0.448). In gilts, removal rates did differ between treatments (P = 0.024) such that 12% of gilts treated with pST from d 25 to 100 of pregnancy were removed before entry into the farrowing house compared with a 5% removal rate in controls (P = 0.062). . Fostering was performed on the day of birth to achieve litter sizes at the beginning of lactation of 10 piglets (where possible) in first-lactation sows, and 12 piglets in older lactating sows. Weaning date, date and reason for all premating removals, numbers mated at the first postweaning estrus, and mating date were recorded for all dams weaned at the end of lactation after the treatment pregnancy. Pregnancy outcomes were recorded for all dams mated at the first postweaning estrus.
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Chi-square analysis of treatment and parity effects and maternal treatment within parity group.
The Kruskal-Wallis test was used for nonparametric data comparisons for analysis of treatment and parity effects and maternal treatment within parity group. Weaning-remating interval data are mean ± SEM.
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Chi-square analysis of treatment and parity effects and maternal treatment within parity group. (Chastant et al., 1994; Sterle et al., 1998) . Furthermore, circulating concentrations of IGF-I increase in pST-treated pigs, with increased expression of IGF-I in maternal liver at the end of pST treatment and no immediate change in IGF-I expression in reproductive tissues, but increased placental IGF-I expression at d 62 of gestation in gilts treated with pST from d 10 to 27 of pregnancy (Sterle et al., 1995 (Sterle et al., , 1998 Freese et al., 2005) . Maternal pST administration increased placental growth in gilts at d 44 of gestation in one study (Sterle et al., 1995) , although not in gilts or sows at d 50 of gestation in a more recent study (Gatford et al., 2009) . We hypothesize that pST increases placental growth to a greater extent in the second half of gestation, and that the smaller uterine size of gilts may limit their capacity for pST-induced increases in placental growth, and hence the capacity to increase the placental exchange area for nutrient transfer. Effects of pST on placental function have not been directly measured in pigs, although fetal plasma glucose was increased after 25 d of maternal pST treatment in gilts, indicative of increased placental function (Gatford et al., 2000) . Maternal ST treatment increases placental nutrient transfer in sheep (Harding et al., 1997) , and increased placental function as well as placental size may contribute to pST-induced increases in fetal growth. Similarly, maternal IGF-I treatment increases placental nutrient transport to the fetus during treatment in early-mid pregnancy as well as at term (Sferruzzi-Perri et al., 2006 , 2007 , which may indicate that pST improves placental function at least partially via increasing maternal circulating IGF-I concentrations.
In the present study, birth weight was increased only after the long-term maternal treatment with pST, although we know that 25 d of maternal pST treatment increases fetal growth at the end of treatment at d 50 in both parities (Gatford et al., 2009 ). This lack of increase in sow and gilt progeny birth weights when pST treatment was discontinued at d 50 of pregnancy is consistent with our previous study in gilts (Gatford et al., 2004) and indicates that effects of pST, for example, on placental development, do not persist sufficiently to maintain heavier fetuses once the increased pST is withdrawn. In sows, but not in gilts, sustained maternal pST treatment also decreased gestation length, possibly because of greater stimulus of maternal endometrial stretch receptors by large piglets combined with the larger litter sizes of sows than gilts. Similarly, in lowrisk human pregnancies, gestation length is longer in small than in large fetuses (Johnsen et al., 2008) . The earlier farrowing increased lactation length in these sows because all pigs are weaned on a single day under commercial management in this piggery, which uses an "all-in, all-out" system to minimize disease transmission. Sows treated with pST from d 25 to 100 of pregnancy were able to maintain similar growth rates in suckling progeny throughout this longer lactation and with heavier litters compared with control dams.
Maternal pST treatment in early-mid pregnancy decreased litter size, regardless of whether the treatment was continued to d 100 of pregnancy. Numbers of mummified piglets were increased (0.16 piglets/litter) after pST treatment between d 25 and 50 of pregnancy; thus, withdrawal of the treatment may induce fetal loss in late pregnancy. This effect did not account for the total decrease in live-born piglets, however, and given that stillbirth numbers did not increase, any loss of fetuses in pST-treated dams must have been early in the treatment period, with subsequent resorption of these conceptuses. This result contrasts with previous studies suggesting that maternal pST increases embryo survival in early-mid gestation in the pig (Kelley et al., 1995) . Treatment with pST at doses approximately 2-fold those in the present study from d 30 to 43 of pregnancy progressively decreased maternal plasma progesterone during treatment (Yuan et al., 1996) , and this might contribute to embryo losses in early pregnancy if it also occurs at these smaller pST doses. Pregnancy failures (numbers that were not in pig at pregnancy check, abortions, or returning to estrus) were not increased in pST-treated gilts or sows, however, indicating that any effects on fetal survival do not act on the litter as a whole.
Differences in piglet BW between groups increased during lactation so that progeny from dams treated with pST from d 25 to 100 of pregnancy were an average of approximately 110 g heavier at birth and approximately 300 g heavier at weaning than progeny of control dams. Piglet growth rates during lactation did not differ between maternal treatments, and the overall increase in treatment effect on piglet weaning weight compared with birth weight could be explained by the shorter gestation lengths in sows given long-term pST treatment. This, combined with weaning on a single day, increased lactation lengths by approximately 1 d in this group so that piglets in this group were older and heavier at weaning. Effects of maternal pST treatment on BW at weaning appear to reflect primarily the increased birth weight of these piglets, with little direct effect on maternal drivers of lactation.
Maternal treatment with pST for 25 or 75 d of pregnancy did not affect rates of pregnancy loss or cull rates of dams during farrowing or lactation, despite piglets being heavier and having an increased demand for milk. Nevertheless, long-term pST treatment increased the numbers of sows culled after weaning of the litter from the treatment pregnancy, mostly because of foot and leg problems or poor body condition. Interestingly, longterm maternal pST in gilts did not increase postweaning cull rates, although maternal pST increased dam BW at farrowing and decreased dam P2 backfat at weaning similarly in sows and gilts. Given that pST increases bone growth and bone density, particularly in adolescents (Mukherjee et al., 2004) , we hypothesize that treating gilts with pST during a period of rapid bone growth may have increased bone density and bone strength, preventing foot and leg problems induced by the increased maternal BW. Treatment with pST stimulates bone resorption and bone formation, and in adult humans, results in a biphasic effect on bone mass, with an initial decrease in bone mass caused by increased bone resorption followed by increasing density as bone formation increases (Ohlsson et al., 1998) . Thus, it is possible that in the adult pig, bone density may have been adversely affected by treatment with pST for 75 d, and this may have contributed to the increased cull rates in sows. Maternal lactation food intake was increased by the sustained gestation pST treatment in gilts and was not altered in sows, which might explain why gilts in this treatment did not have increased cull rates for poor body condition at weaning. This also suggests that sustained pST treatment at approximately 15 µg/kg per day does not adversely affect gut health. Indeed, the doses at which gastric ulceration is reported to occur in lactating sows are 2 or 4 times the dose in the present study (Smith et al., 1991) . Sows that were culled postweaning had decreased fat reserves before mating, weaned heavier litters, and ate less during lactation. This indicates that culling may remove productive sows from the herd, and retaining sows in poor body condition so they can regain body condition before mating should be considered. Maintaining increased lactation feed intake or adopting a management system, such as skip-a-heat mating (Clowes et al., 1994) , to allow the sow to regain body condition may be necessary to avoid possible adverse effects of maternal pST on sow retention. In those dams that were mated after weaning, neither parity nor pST treatment affected the weaningremating interval, conception rate, or subsequent litter size, confirming that these treatments did not adversely affect subsequent reproduction in a pregnancy without further administration of pST.
Our results show that long-term maternal pST treatment during pregnancy increased birth weight in gilts and sows, with the responses approximately 2-fold greater in the latter. Similar to previous studies in gilts, pST treatment only in early-mid pregnancy did not increase progeny size at birth. Using strategies to increase lactation feed intake, managing the sow differently after weaning, or both may improve progeny growth in lactation and prevent adverse effects on postweaning cull rates in sows. We are now investigating whether long-term pST treatment can also increase postweaning progeny growth and performance to a greater extent in sows than in gilts.
In the present study, long-term maternal ST treatment increased progeny birth and weaning weights to a greater extent in sows than in gilts. These benefits of maternal pST treatment from d 25 to 100 of gestation were partially offset by a 0.6-piglet reduction in numbers of live-born piglets and a 12% increase in sow, but not gilt, cull rates after weaning. Strategies to increase maternal bone strength and reduce maternal BW loss during lactation are needed to avoid increased cull rates of multiparous sows treated with pST during the previous pregnancy. The mean increases of 7.3% in birth weight (corrected for litter size) and 4.2% in weaning weight in dams treated with pST for 75 d from early to late pregnancy are likely to improve subsequent growth rates and performance of progeny. These are currently being evaluated.
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